Big Pharma Has A Rare Week – CounterPunch

by admin on February 27, 2013

Big Pharma Has A Rare Week
CounterPunch
If approved for the new indication, chronic idiopathic urticaria will likely became a major U.S. health problem to be advertised on TV like restless legs syndrome. Ka-ching. Genetically engineered drugs like Xolair (called monoclonal antibodies) cost

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: